Client Challenges
Chronic peripheral nerve pain is debilitating, costly, and often unresponsive to conventional therapies. While Nalu Medical’s Peripheral Nerve Stimulation (PNS) System has shown strong clinical promise as a minimally invasive, drug-free approach to pain management, payer reimbursement of PNS therapies is limited by a lack of clear evidence demonstrating its economic value. To differentiate their microimplantable pulse generator (micro-IPG) technology from the standard of care and expand patient access, Nalu needed rigorous, independent real-world evidence that not only confirmed clinical benefit but also quantified reductions in healthcare utilization and the overall cost of care.
View the full case study.